High-Throughput Screening for GPR119 Modulators Identifies a Novel Compound With Anti-Diabetic Efficacy in Db/db Mice.
High-Throughput Screening for GPR119 Modulators Identifies a Novel Compound with Anti-Diabetic Efficacy in db/db Mice.
PLoS One. 2013; 8(5): e63861
Zhang M, Feng Y, Wang J, Zhao J, Li T, He M, Yang D, Nosjean O, Boutin J, Renard… Continue reading
Polymorphisms in the F8 Gene and MHC-II Variants as Risk Factors for the Development of Inhibitory Anti-Factor VIII Antibodies During the Treatment of Hemophilia A: A Computational Assessment.
Polymorphisms in the F8 Gene and MHC-II Variants as Risk Factors for the Development of Inhibitory Anti-Factor VIII Antibodies during the Treatment of Hemophilia A: A Computational Assessment.
PLoS Comput Biol. 2013 May; 9(5): e1003066
Pandey GS, Yanover C,… Continue reading
Testing Jessor’s Problem Behavior Theory and Syndrome: A Nationally Representative Comparative Sample of Latino and African American Adolescents.
Testing Jessor’s problem behavior theory and syndrome: A nationally representative comparative sample of Latino and African American adolescents.
Cultur Divers Ethnic Minor Psychol. 2013 Apr; 19(2): 190-9
Mobley M, Chun H
Based on Jessor’s problem behavior theory (PBT; R.… Continue reading
A New Class of Small Molecule Inhibitor of BMP Signaling.
A New Class of Small Molecule Inhibitor of BMP Signaling.
PLoS One. 2013; 8(4): e62721
Sanvitale CE, Kerr G, Chaikuad A, Ramel MC, Mohedas AH, Reichert S, Wang Y, Triffitt JT, Cuny GD, Yu PB, Hill CS, Bullock AN… Continue reading
Update on the Treatment of Non-Small-Cell Lung Cancer: Focus on the Cost-Effectiveness of New Agents.
Update on the treatment of non-small-cell lung cancer: focus on the cost-effectiveness of new agents.
Clinicoecon Outcomes Res. 2013; 5: 137-41
Vergnenègre A, Borget I, Chouaid C
The incidence of lung cancer and the cost of drug treatment have… Continue reading